Carnegie Capital Asset Management, LLC Ventyx Biosciences, Inc. Transaction History

Carnegie Capital Asset Management, LLC

  • $3.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023
BUY
$28.53 - $39.55 $142,650 - $197,750
5,000 Added 50.0%
15,000 $491,000
Q1 2023

Apr 19, 2023
SELL
$29.51 - $46.65 $168,443 - $266,278
-5,708 Reduced 36.34%
10,000 $335,000
Q4 2022

Jan 23, 2023
BUY
$24.16 - $36.38 $379,505 - $571,457
15,708 New
15,708 $0

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $132M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email